ArticlePediatric radiology2026
3D-QALAS synthetic MRI with Zero-DeepSub in children: initial experience including post-contrast imaging feasibility.
Article in Pediatric radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- My MRI sequence is better than yours: not so easy.Pediatric radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundMagnetic resonance imaging (MRI) in children requires multiple sequences, leading to lengthy exams and motion-related challenges. Synthetic MRI generates multiple contrasts from a single acquisition, and integration of 3D-quantification using an interleaved Look-Locker acquisition sequence with a T2 preparation pulse (3D-QALAS) sequence with scan-specific deep-learning-based subspace reconstruction (Zero-DeepSub) enables high-resolution isotropic imaging with potential clinical utility.
objectiveTo evaluate synthetic images generated from a 3D-QALAS sequence with Zero-DeepSub relative to conventional MRI sequences in pediatric brain MRI. MATERIALS AND
methodsThis prospective initial experience included 26 pediatric patients (mean age 8.4 years) who underwent clinically indicated brain MRI between November 2023 and January 2024. Synthetic T1-weighted, T2-weighted, and fluid-attenuated inversion recovery (FLAIR) images were generated from quantitative maps using 3D-QALAS with Zero-DeepSub reconstruction. Two neuroradiologists independently assessed seven predefined imaging findings on synthetic and conventional images, with discrepancies adjudicated by a third reader. This reader also performed a semiquantitative evaluation of image quality using a 5-point Likert scale. Statistical analysis included descriptive statistics, interobserver agreement (Cohen's kappa), and Wilcoxon signed-rank tests; positive predictive value (PPV) and negative predictive value (NPV) were also calculated.
resultsSynthetic images showed high sensitivity and specificity for mass/lesion, encephalomalacia, and collections, with perfect reader agreement. Gliosis demonstrated high sensitivity but moderate specificity for one reader. Abnormal enhancement had the lowest sensitivity (0.40). Interobserver agreement was moderate for gliosis (κ=0.55) and almost perfect (κ=0.83-1.00) for other findings. Semiquantitative evaluation revealed no significant difference between synthetic and conventional FLAIR, T1-weighted imaging, or post-contrast sequences (P>0.1), while conventional T2-weighted imaging was significantly superior (P<0.001).
conclusion3D-QALAS with Zero-DeepSub reconstruction enables the synthesis of high-resolution, clinically interpretable brain images in pediatric patients, including post-contrast sequences. While conventional T2-weighted imaging remained superior, other synthetic contrasts were rated comparable to conventional images. This promising technique holds potential to reduce scan times in pediatric neuroimaging protocols, but further optimization and validation are required before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.